Chemours Co. Files 8-K on Listing Rule Compliance
Ticker: CC · Form: 8-K · Filed: Mar 19, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: listing-rule, compliance, financials
TL;DR
Chemours 8-K: Potential listing rule issues, filing financials.
AI Summary
On March 18, 2024, The Chemours Company filed an 8-K report to address a notice of delisting or failure to satisfy a continued listing rule. The company is also filing financial statements and exhibits as part of this report. The filing pertains to the company's status as of March 18, 2024.
Why It Matters
This filing indicates potential issues with Chemours' continued listing on an exchange, which could impact investor confidence and stock liquidity.
Risk Assessment
Risk Level: medium — Filings related to listing rules can signal underlying financial or operational difficulties that may affect the company's stock.
Key Numbers
- 001-36794 — SEC File Number (Identifies the company's filing with the SEC.)
- 46-4845564 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- The Chemours Company (company) — Registrant
- Delaware (location) — State of Incorporation
- 1007 Market Street Wilmington, Delaware 19801 (address) — Principal executive offices
FAQ
What specific listing rule is Chemours failing to satisfy?
The filing does not specify the exact listing rule that Chemours may be failing to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is March 18, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.
What is the company's state of incorporation?
The Chemours Company is incorporated in Delaware.
What other items are being filed as part of this 8-K?
In addition to the notice of delisting, the company is filing 'Financial Statements and Exhibits'.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-03-18 18:32:53
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- d809954d8k.htm (8-K) — 24KB
- d809954dex991.htm (EX-99.1) — 12KB
- g809954dsp05.jpg (GRAPHIC) — 11KB
- g809954dsp06.jpg (GRAPHIC) — 5KB
- g809954g0319020731055.jpg (GRAPHIC) — 3KB
- 0001193125-24-070332.txt ( ) — 185KB
- cc-20240318.xsd (EX-101.SCH) — 3KB
- cc-20240318_lab.xml (EX-101.LAB) — 17KB
- cc-20240318_pre.xml (EX-101.PRE) — 11KB
- d809954d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits Exhibit No. Description 99.1 Press release dated March 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY Date: March 18, 2024 By: /s/ Matthew S. Abbott Name: Matthew S. Abbott Title: Interim Chief Financial Officer